nanocomplex Search Results


90
BioMimetic Therapeutics lipid nanocomplexes incorporating stat3-inhibiting peptides
Lipid Nanocomplexes Incorporating Stat3 Inhibiting Peptides, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lipid nanocomplexes incorporating stat3-inhibiting peptides/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
lipid nanocomplexes incorporating stat3-inhibiting peptides - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
NanoCarrier Co fa-hp-β-cd-pei/dox nanocomplexes
Fa Hp β Cd Pei/Dox Nanocomplexes, supplied by NanoCarrier Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fa-hp-β-cd-pei/dox nanocomplexes/product/NanoCarrier Co
Average 90 stars, based on 1 article reviews
fa-hp-β-cd-pei/dox nanocomplexes - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics nanocomplex
Nanocomplex, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nanocomplex/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
nanocomplex - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Quantum Dot Inc quantum-dot nanocomplexes
Quantum Dot Nanocomplexes, supplied by Quantum Dot Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quantum-dot nanocomplexes/product/Quantum Dot Inc
Average 90 stars, based on 1 article reviews
quantum-dot nanocomplexes - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics cell membrane camouflaged biomimetic nanocomplex based on black phosphorous nanosheets
Cell Membrane Camouflaged Biomimetic Nanocomplex Based On Black Phosphorous Nanosheets, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell membrane camouflaged biomimetic nanocomplex based on black phosphorous nanosheets/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
cell membrane camouflaged biomimetic nanocomplex based on black phosphorous nanosheets - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics spherical biomimetic enzyme nanocomplexes
Spherical Biomimetic Enzyme Nanocomplexes, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spherical biomimetic enzyme nanocomplexes/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
spherical biomimetic enzyme nanocomplexes - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics sirna nanocarriers
Sirna Nanocarriers, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirna nanocarriers/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
sirna nanocarriers - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Quantum Dot Inc quantum dot-amphipol nanocomplex
Quantum Dot Amphipol Nanocomplex, supplied by Quantum Dot Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quantum dot-amphipol nanocomplex/product/Quantum Dot Inc
Average 90 stars, based on 1 article reviews
quantum dot-amphipol nanocomplex - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Nanoprobes Inc liposome-peg-mno nanocomplex
. (A) Cell viability of 786-O cells and EA.hy926 cells incubated with different concentrations of liposome-PEG-MnO <t>nanocomplex.</t> (B) The changes in body weight of mice post-injection of saline or liposome-PEG-MnO nanocomplex. (C) Histological images of the heart, liver, spleen, kidney and lung of mice 1 day or 7 day post-injection of liposome-PEG-MnO nanocomplex.
Liposome Peg Mno Nanocomplex, supplied by Nanoprobes Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/liposome-peg-mno nanocomplex/product/Nanoprobes Inc
Average 90 stars, based on 1 article reviews
liposome-peg-mno nanocomplex - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Sirna Therapeutics nanocomplex
. (A) Cell viability of 786-O cells and EA.hy926 cells incubated with different concentrations of liposome-PEG-MnO <t>nanocomplex.</t> (B) The changes in body weight of mice post-injection of saline or liposome-PEG-MnO nanocomplex. (C) Histological images of the heart, liver, spleen, kidney and lung of mice 1 day or 7 day post-injection of liposome-PEG-MnO nanocomplex.
Nanocomplex, supplied by Sirna Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nanocomplex/product/Sirna Therapeutics
Average 90 stars, based on 1 article reviews
nanocomplex - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
NanoVector ppdp/pdna nanocomplexes
Cytotoxicity of PPDP/pDNA nanovector in RAW 264.7 macrophages RAW 264.7 macrophages were incubated with PPDP/pDNA <t>nanocomplexes</t> that were prepared with a different polymer to pDNA ratios (30:1, 60:1, 120:1) for 24 h at 37 °C. Untreated cells (Control), Lipo2K/pDNA complexes (Lipo2K), PEI/pDNA complexes (PEI with the molecular weight of 25 kDa), and dendritic peptide (DP)/pDNA complexes were included as benchmarks. The cell viability for (a) PPDP/S-pDNA complexes and (b) PPDP/L-pDNA complexes was then measured by the MTT assay. Asterisks indicate the experimentally determined optimal ratio for each formulation. Data are presented as the mean ± SD (n = 3).
Ppdp/Pdna Nanocomplexes, supplied by NanoVector, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ppdp/pdna nanocomplexes/product/NanoVector
Average 90 stars, based on 1 article reviews
ppdp/pdna nanocomplexes - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
CH Instruments nanocomplexes with pcem-trail
Cytotoxicity of PPDP/pDNA nanovector in RAW 264.7 macrophages RAW 264.7 macrophages were incubated with PPDP/pDNA <t>nanocomplexes</t> that were prepared with a different polymer to pDNA ratios (30:1, 60:1, 120:1) for 24 h at 37 °C. Untreated cells (Control), Lipo2K/pDNA complexes (Lipo2K), PEI/pDNA complexes (PEI with the molecular weight of 25 kDa), and dendritic peptide (DP)/pDNA complexes were included as benchmarks. The cell viability for (a) PPDP/S-pDNA complexes and (b) PPDP/L-pDNA complexes was then measured by the MTT assay. Asterisks indicate the experimentally determined optimal ratio for each formulation. Data are presented as the mean ± SD (n = 3).
Nanocomplexes With Pcem Trail, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nanocomplexes with pcem-trail/product/CH Instruments
Average 90 stars, based on 1 article reviews
nanocomplexes with pcem-trail - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


. (A) Cell viability of 786-O cells and EA.hy926 cells incubated with different concentrations of liposome-PEG-MnO nanocomplex. (B) The changes in body weight of mice post-injection of saline or liposome-PEG-MnO nanocomplex. (C) Histological images of the heart, liver, spleen, kidney and lung of mice 1 day or 7 day post-injection of liposome-PEG-MnO nanocomplex.

Journal: RSC Advances

Article Title: AS1411 aptamer-modified theranostic liposomes co-encapsulating manganese oxide nano-contrast agent and paclitaxel for MRI and therapy of cancer

doi: 10.1039/c9ra06878c

Figure Lengend Snippet: . (A) Cell viability of 786-O cells and EA.hy926 cells incubated with different concentrations of liposome-PEG-MnO nanocomplex. (B) The changes in body weight of mice post-injection of saline or liposome-PEG-MnO nanocomplex. (C) Histological images of the heart, liver, spleen, kidney and lung of mice 1 day or 7 day post-injection of liposome-PEG-MnO nanocomplex.

Article Snippet: Such signal began to reduce after 4 h and disappeared after 48 h. Similarly with liposome-PEG-MnO nanocomplex, the injected AS1411-liposome-PEG-MnO nanoprobes were excreted from the body via the hepatobiliary system.

Techniques: Incubation, Injection, Saline

Cytotoxicity of PPDP/pDNA nanovector in RAW 264.7 macrophages RAW 264.7 macrophages were incubated with PPDP/pDNA nanocomplexes that were prepared with a different polymer to pDNA ratios (30:1, 60:1, 120:1) for 24 h at 37 °C. Untreated cells (Control), Lipo2K/pDNA complexes (Lipo2K), PEI/pDNA complexes (PEI with the molecular weight of 25 kDa), and dendritic peptide (DP)/pDNA complexes were included as benchmarks. The cell viability for (a) PPDP/S-pDNA complexes and (b) PPDP/L-pDNA complexes was then measured by the MTT assay. Asterisks indicate the experimentally determined optimal ratio for each formulation. Data are presented as the mean ± SD (n = 3).

Journal: iScience

Article Title: Dendritic peptide-conjugated polymeric nanovectors for non-toxic delivery of plasmid DNA and enhanced non-viral transfection of immune cells

doi: 10.1016/j.isci.2022.104555

Figure Lengend Snippet: Cytotoxicity of PPDP/pDNA nanovector in RAW 264.7 macrophages RAW 264.7 macrophages were incubated with PPDP/pDNA nanocomplexes that were prepared with a different polymer to pDNA ratios (30:1, 60:1, 120:1) for 24 h at 37 °C. Untreated cells (Control), Lipo2K/pDNA complexes (Lipo2K), PEI/pDNA complexes (PEI with the molecular weight of 25 kDa), and dendritic peptide (DP)/pDNA complexes were included as benchmarks. The cell viability for (a) PPDP/S-pDNA complexes and (b) PPDP/L-pDNA complexes was then measured by the MTT assay. Asterisks indicate the experimentally determined optimal ratio for each formulation. Data are presented as the mean ± SD (n = 3).

Article Snippet: Figure 3 Cytotoxicity of PPDP/pDNA nanovector in RAW 264.7 macrophages RAW 264.7 macrophages were incubated with PPDP/pDNA nanocomplexes that were prepared with a different polymer to pDNA ratios (30:1, 60:1, 120:1) for 24 h at 37 °C.

Techniques: Incubation, Polymer, Control, Molecular Weight, MTT Assay, Formulation

Optimization of PPDP/pDNA nanovectors for enhanced DNA binding capability Electrophoretic mobility shift assay (EMSA) of PPDP/pDNA nanocomplexes with different polymer to pDNA ratios from 1:1 to 60:1. Naked pDNA, Lipofectamine 2000/pDNA complexes (Lipo2K), PEI/pDNA complexes (PEI with the molecular weight of 25 kDa), and dendritic peptide (DP1)/pDNA complexes were included as control groups. PPDP formulations were optimized by complexing with (a) S-pDNA and (b) L-pDNA. (red triangle points to PPDP/pDNA nanocomplexes that quenched the GelRed® nucleic acid stain). Effect of the mass ratio of (c) PPDP2:S-pDNA and PPDP5:S-pDNA and, (d) PPDP2:L-pDNA and PPDP5:L-pDNA on the nanocomplex particle size (red) and zeta potential (blue). Asterisks indicate the optimal PPDP:pDNA ratio. Data are presented as the mean ± SD (n = 3). e,f) Representative Cryo-TEM micrographs of the optimal PPDP/pDNA nanocomplexes. Scale bar = 100 nm.

Journal: iScience

Article Title: Dendritic peptide-conjugated polymeric nanovectors for non-toxic delivery of plasmid DNA and enhanced non-viral transfection of immune cells

doi: 10.1016/j.isci.2022.104555

Figure Lengend Snippet: Optimization of PPDP/pDNA nanovectors for enhanced DNA binding capability Electrophoretic mobility shift assay (EMSA) of PPDP/pDNA nanocomplexes with different polymer to pDNA ratios from 1:1 to 60:1. Naked pDNA, Lipofectamine 2000/pDNA complexes (Lipo2K), PEI/pDNA complexes (PEI with the molecular weight of 25 kDa), and dendritic peptide (DP1)/pDNA complexes were included as control groups. PPDP formulations were optimized by complexing with (a) S-pDNA and (b) L-pDNA. (red triangle points to PPDP/pDNA nanocomplexes that quenched the GelRed® nucleic acid stain). Effect of the mass ratio of (c) PPDP2:S-pDNA and PPDP5:S-pDNA and, (d) PPDP2:L-pDNA and PPDP5:L-pDNA on the nanocomplex particle size (red) and zeta potential (blue). Asterisks indicate the optimal PPDP:pDNA ratio. Data are presented as the mean ± SD (n = 3). e,f) Representative Cryo-TEM micrographs of the optimal PPDP/pDNA nanocomplexes. Scale bar = 100 nm.

Article Snippet: Figure 3 Cytotoxicity of PPDP/pDNA nanovector in RAW 264.7 macrophages RAW 264.7 macrophages were incubated with PPDP/pDNA nanocomplexes that were prepared with a different polymer to pDNA ratios (30:1, 60:1, 120:1) for 24 h at 37 °C.

Techniques: Binding Assay, Electrophoretic Mobility Shift Assay, Polymer, Molecular Weight, Control, Staining, Zeta Potential Analyzer

Endosomal escape and cytosolic delivery of PPDP2/pDNA complexes in RAW 264.7 macrophages RAW 264.7 macrophages were incubated with PPDP2/AF488-labeled S-pDNA (pcDNA3.1, 5.4 kb) nanocomplexes formed using a PPDP2 to pDNA weight ratio of 60:1. Representative confocal images display PPDP2/S-pDNA complexes within cells after 1, 4, and 18 h incubation periods. LysoTracker red was used to label late endosomes/lysosomes. Nuclei were stained with DAPI (blue). Co-localization of green plasmid DNA and red endo/lysosomes appears as yellow in the images. Scale bar = 10 μm.

Journal: iScience

Article Title: Dendritic peptide-conjugated polymeric nanovectors for non-toxic delivery of plasmid DNA and enhanced non-viral transfection of immune cells

doi: 10.1016/j.isci.2022.104555

Figure Lengend Snippet: Endosomal escape and cytosolic delivery of PPDP2/pDNA complexes in RAW 264.7 macrophages RAW 264.7 macrophages were incubated with PPDP2/AF488-labeled S-pDNA (pcDNA3.1, 5.4 kb) nanocomplexes formed using a PPDP2 to pDNA weight ratio of 60:1. Representative confocal images display PPDP2/S-pDNA complexes within cells after 1, 4, and 18 h incubation periods. LysoTracker red was used to label late endosomes/lysosomes. Nuclei were stained with DAPI (blue). Co-localization of green plasmid DNA and red endo/lysosomes appears as yellow in the images. Scale bar = 10 μm.

Article Snippet: Figure 3 Cytotoxicity of PPDP/pDNA nanovector in RAW 264.7 macrophages RAW 264.7 macrophages were incubated with PPDP/pDNA nanocomplexes that were prepared with a different polymer to pDNA ratios (30:1, 60:1, 120:1) for 24 h at 37 °C.

Techniques: Incubation, Labeling, Staining, Plasmid Preparation